In last trading session, Tvardi Therapeutics Inc (NASDAQ:TVRD) saw 0.51 million shares changing hands with its beta currently measuring 0.22. Company’s recent per share price level of $24.61 trading at -$0.6 or -2.38% at ring of the bell on the day assigns it a market valuation of $230.37M. That closing price of TVRD’s stock is at a discount of -39.41% from its 52-week high price of $34.31 and is indicating a premium of 66.96% from its 52-week low price of $8.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 48.08K if we extend that period to 3-months.
Tvardi Therapeutics Inc (NASDAQ:TVRD) trade information
Upright in the red during last session for losing -2.38%, in the last five days TVRD remained trading in the red while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $24.61 price level, adding 14.34% to its value on the day. Tvardi Therapeutics Inc’s shares saw a change of 101.12% in year-to-date performance and have moved -4.50% in past 5-day. Tvardi Therapeutics Inc (NASDAQ:TVRD) showed a performance of -20.25% in past 30-days. Number of shares sold short was 9554.0 shares which calculate 0.26 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 78 to the stock, which implies a rise of 68.45% to its current value. Analysts have been projecting 78 as a low price target for the stock while placing it at a high target of 78. It follows that stock’s current price would drop -216.94% in reaching the projected high whereas dropping to the targeted low would mean a loss of -216.94% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.29% during past 5 years.
Tvardi Therapeutics Inc (NASDAQ:TVRD)’s Major holders
Insiders are in possession of 27.53% of company’s total shares while institution are holding 2.76 percent of that, with stock having share float percentage of 3.81%. Investors also watch the number of corporate investors in a company very closely, which is 2.76% institutions for Tvardi Therapeutics Inc that are currently holding shares of the company.
